Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.2M Buy
50,500
+15,500
+44% +$4.22M ﹤0.01% 1543
2026
Q2
$11.7M Buy
35,000
+21,400
+157% +$6.79M ﹤0.01% 1405
2026
Q1
$3.41M Sell
13,600
-6,400
-32% -$1.42M ﹤0.01% 2047
2025
Q4
$3.24M Buy
+20,000
New +$3.47M ﹤0.01% 2573
2025
Q3
– Sell
-3,098,900
Closed -$398M – 5751
2025
Q2
$398M Buy
3,098,900
+3,015,900
+3,634% +$293M 0.09% 145
2025
Q1
$5.99M Buy
+83,000
New +$8.83M ﹤0.01% 1767
2024
Q2
– Sell
-300,000
Closed -$24.5M – 5329
2024
Q1
$24.5M Buy
+300,000
New +$18.9M 0.01% 899

Other funds holding VRT

Barclays's VRT Position: Q3 2026 in Review

Barclays reduced its Vertiv (VRT) stake by 48% in Q3 2026, selling an estimated $192M and leaving 774,298 shares worth $187M. The position accounts for 0.04% of the portfolio, ranked #307.

Barclays first reported a position in VRT in Q1 2022 and has held it in 19 quarters since. The position peaked at $495M in Q2 2026. 1,883 funds tracked by Wall St. Rank hold VRT as of Q3 2026.

  • Barclays held 774,298 shares of Vertiv worth $187M as of Q3 2026.
  • Barclays sold 703,564 Vertiv shares in Q3 2026, an estimated $192M.
  • Vertiv made up 0.04% of Barclays's portfolio in Q3 2026, its #307 holding.
  • Barclays first reported a position in Vertiv in Q1 2022 and has held it in 19 quarters since.
  • Barclays's Vertiv position peaked at $495M in Q2 2026.
  • 1,883 funds tracked by Wall St. Rank held Vertiv as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.